Analyst Ratings For NASDAQ:DXCM – Dexcom (NASDAQ:DXCM)
Today, Canaccord Genuity raised its price target on NASDAQ:DXCM – Dexcom (NASDAQ:DXCM) to $85.00 per share.
Some recent analyst ratings include
- 5/3/2018-BTIG Research Reiterated Rating of Hold.
- 4/9/2018-Stephens Reiterated Rating of Buy.
- 4/4/2018-Goldman Sachs initiated coverage with a Sell rating.
- 4/3/2018-Guggenheim initiated coverage with a Neutral rating.
- On 4/23/2018 Richard Doubleday, EVP, sold 2,581 with an average share price of $73.09 per share and the total transaction amounting to $188,645.29.
- On 4/16/2018 Terrance H Gregg, Insider, sold 10,000 with an average share price of $73.04 per share and the total transaction amounting to $730,400.00.
- On 3/23/2018 Richard Doubleday, EVP, sold 2,581 with an average share price of $68.44 per share and the total transaction amounting to $176,643.64.
- On 3/15/2018 Terrance H Gregg, Insider, sold 10,000 with an average share price of $65.51 per share and the total transaction amounting to $655,100.00.
- On 2/23/2018 Richard Doubleday, EVP, sold 1,638 with an average share price of $56.32 per share and the total transaction amounting to $92,252.16.
- On 2/15/2018 Terrance H Gregg, Chairman, sold 10,000 with an average share price of $55.91 per share and the total transaction amounting to $559,100.00.
- On 1/23/2018 Richard Doubleday, EVP, sold 1,635 with an average share price of $54.67 per share and the total transaction amounting to $89,385.45.
Recent Trading Activity for NASDAQ:DXCM – Dexcom (NASDAQ:DXCM)
Shares of NASDAQ:DXCM – Dexcom closed the previous trading session at 80.10 up +5.79 7.79% with shares trading hands.